Recognition and Management of Oral Mucosal Injury Caused by Mammalian Target of Rapamycin Inhibitors: A Case Series

Publisher： Karger

E-ISSN： 1662-6575|8|2|369-377

ISSN： 1662-6575

Source： Case Reports in Oncology, Vol.8, Iss.2, 2015-08, pp. : 369-377

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Promising Activity of Mammalian Target of Rapamycin Inhibitors in Hematologic Malignancies Therapy

By  

Current Signal Transduction Therapy, Vol. 6, Iss. 1, 2011-01 ,pp. : 44-54

Bentham Science Publishers

Access to resources Recommend Favorite

Mammalian Target of Rapamycin Inhibitors Resistance Mechanisms in Clear Cell Renal Cell Carcinoma

By  

Current Signal Transduction Therapy, Vol. 8, Iss. 3, 2013-01 ,pp. : 210-218

Bentham Science Publishers

Access to resources Recommend Favorite

Conversion to mammalian target of rapamycin inhibitors increases risk of de novo donor‐specific antibodies

By  

TRANSPLANT INTERNATIONAL (ELECTRONIC), Vol. 27, Iss. 8, 2014-08 ,pp. : 775-783

John Wiley & Sons Inc

Access to resources Recommend Favorite

Safety considerations of mammalian target of rapamycin inhibitors in tuberous sclerosis complex and renal transplantation

By  

JOURNAL OF CLINICAL PHARMACOLOGY (ELECTRONIC), Vol. 55, Iss. 4, 2015-04 ,pp. : 368-376

John Wiley & Sons Inc

Access to resources Recommend Favorite

Mammalian Target of Rapamycin as a Rational Therapeutic Target for Breast Cancer Treatment

By  

Oncology, Vol. 84, Iss. 1, 2012-10 ,pp. : 43-56

Karger

Access to resources Recommend Favorite